Thomas W. Campi, DVM, MPVM is the CEO of Modulant Biosciences, a new company with therapies for diseases in food and companion animals, and CSO for Veloviapharma, a veterinary drug development company. Dr. Campi's career spans 35 years and includes leadership roles in regulatory, research and technology acquisitions at Elanco, and Head of Research and Regulatory Affairs at Huvepharma. He was also a founder and partner in Reliance Animal Health Partners. Tom received his veterinary degrees from the University of California, Davis.